Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis

Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis

Patient-reported quality-of-life (QoL) and carer impacts are not reported after leucine-rich glioma-inactivated 1-antibody encephalitis (LGI1-Ab-E). From 60 patients, 85% (51 out of 60) showed one abnormal score across QoL assessments and 11 multimodal validated questionnaires. Compared to the premo...

Full description

Bibliographic Details
Main Authors:	Binks, SNM, Veldsman, M, Handel, AE, Jacob, S, Maddison, P, Coebergh, J, Michael, S, Ramanathan, S, Easton, A, Nissen, MS, Leite, MI, Okai, D, Blaabjerg, M, Husain, M, Irani, SR
Format:	Journal article
Language:	English
Published:	Wiley 2024

Similar Items

Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis
by: Sophie N. M. Binks, et al.
Published: (2024-04-01)

Changes in the rate of leucine-rich glioma-inactivated 1 seropositivity during the COVID-19 lockdown
by: Handel, AE, et al.
Published: (2023)

Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies
by: Mariem Messelmani, et al.
Published: (2015-01-01)

Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
by: Naasan, G, et al.
Published: (2014)

Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
by: Binks, S, et al.
Published: (2020)

EEG characteristics of anti ⁃ leucine ⁃ rich glioma ⁃ inactivated 1 antibody ⁃ associated encephalitis
by: ZHANG Yi⁃fan, et al.
Published: (2023-12-01)

Clinical characteristics of anti ⁃ leucine ⁃ rich glioma ⁃ inactivated 1 antibody associated encephalitis
by: PAN He⁃yue, et al.
Published: (2023-10-01)

Clinical analysis of anti⁃leucine⁃rich glioma⁃inactivated 1 antibody⁃related encephalitis
by: Qing⁃qing ZHAO, et al.
Published: (2020-09-01)

Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.
by: Irani, SR, et al.
Published: (2014)

‘Less contented as a person’: an update from the LGI1-QoL study
by: Binks, S, et al.
Published: (2019)

Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.
by: Brown, J, et al.
Published: (2014)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
by: Wei M, et al.
Published: (2020-01-01)

Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Single-Center Cohort Study in China
by: FAN Siyuan, et al.
Published: (2022-04-01)

Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature
by: Sanaz Ahmadi Karvigh, et al.
Published: (2022-11-01)

Clinical analysis of patients with anti-leucine-rich glioma-inactivated 1 antibody-associated limbic encephalitis
by: Jia-qian TANG, et al.
Published: (2019-04-01)

Leucine-rich glioma-inactivated 1 versus contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons
by: Ramanathan, S, et al.
Published: (2021)

Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report
by: Lan Hou, et al.
Published: (2022-07-01)

Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report
by: Ayush Adhikari, et al.
Published: (2020-07-01)

Clinical and electroencephalographic characteristics of symptomatic episodes in anti⁃leucine rich glioma inactivated 1 antibody⁃associated autoimmune encephalitis
by: LI Cheng⁃yu, et al.
Published: (2023-03-01)

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
by: Jinyi Li, et al.
Published: (2023-01-01)

A case of leucine-rich glioma-inactivated 1 antibody encephalitis with schizophrenia-like symptoms as an initial clinical manifestation
by: Jiyeon Moon, et al.
Published: (2022-10-01)

Serial assessment of multimodality imaging in anti-leucine-rich glioma-inactivated 1 antibody encephalitis: A case report
by: Takafumi Wada, et al.
Published: (2022-12-01)

Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis—A Pilot Study
by: Xueying Ma, et al.
Published: (2020-10-01)

Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on 18F-FDG PET
by: Kai Wang, et al.
Published: (2023-03-01)

Arterial Spin Labeling Imaging Characteristics of Anti-leucine-rich Glioma-Inactivated 1 Encephalitis: A Qualitative and Quantitative Analysis
by: Vivek Srikar Yedavalli, et al.
Published: (2022-07-01)

The First Case of Familiar Anti-leucine-rich Glioma-Inactivated1 Autoimmune Encephalitis: A Case Report and Literature Review
by: Chuhan Ding, et al.
Published: (2022-04-01)

Anti-leucine-rich glioma-inactivated 1 antibody-associated encephalitis with unilateral basal ganglia hyperintensity: one case report
by: Xuan CHEN, et al.
Published: (2018-05-01)

Discrimination between leucine-rich glioma-inactivated 1 antibody encephalitis and gamma-aminobutyric acid B receptor antibody encephalitis based on ResNet18
by: Jian Pan, et al.
Published: (2023-08-01)

A rare case of leucine-rich glioma-inactivated 1 encephalitis presenting with neurocognitive and affective symptoms in an elderly female − Case report
by: S. Neethu, et al.
Published: (2024-03-01)

Leucine-rich glioma-inactivated protein 1 antibody-associated encephalitis in a 22-month-old girl: a case report
by: JiaChang Zhao, et al.
Published: (2023-08-01)

Leucine-Rich glioma-inactivated protein 1 antibody-positive limbic encephalitis in a patient with adenocarcinoma of prostate: A case report
by: Devaraddi Navalli, et al.
Published: (2019-01-01)

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
by: Irani, S, et al.
Published: (2010)

A feline model of spontaneously occurring autoimmune limbic encephalitis
by: Glantschnigg-Eisl, U, et al.
Published: (2023)

‘Less contented as a person’: preliminary data from the LGI1-QoL study
by: Binks, S, et al.
Published: (2017)

Clinical Features and Electroencephalogram Analysis of Brain Network Functional Connectivity in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
by: Guo X, et al.
Published: (2024-10-01)

Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features
by: Shan Qiao, et al.
Published: (2023-08-01)

Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews
by: Liqing Chen, et al.
Published: (2023-06-01)

Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis
by: Kelly, MJ, et al.
Published: (2024)

Leucine-rich Glioma Inactivated 1 (LGI-1) Limbic Encephalitis Presenting with Psychotic Symptoms without Seizures: A Case Report with Five-year Follow-up and Review of Literature
by: Harkishan Mamtani, et al.
Published: (2024-07-01)

Heterogeneity of clinical features, EEG and brain imaging findings in anti-leucine-rich glioma-inactivated protein 1 autoimmune encephalitis: a retrospective case series study and review of the literature
by: Emily Yixuan Huang, et al.
Published: (2023-08-01)